Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q2 2026)
2,530,290
Value
$25.3M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of BCRX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,530,290$25.3M<0.1%+1,753,300+225.7%AddedHolders
Q1 2026776,990$7.40M<0.1%−1,351,831−63.5%ReducedHolders
Q4 20252,128,821$16.6M<0.1%−11,713−0.5%ReducedHolders
Q3 20252,140,534$16.2M<0.1%−386,200−15.3%ReducedHolders
Q2 20252,526,734$22.6M<0.1%+1,921,516+317.5%AddedHolders
Q1 2025605,218$4.54M<0.1%+60,197+11.0%AddedHolders
Q4 2024545,021$4.10M<0.1%−44,059−7.5%ReducedHolders
Q3 2024589,080$4.48M<0.1%−371,100−38.6%ReducedHolders
Q2 2024960,180$5.93M<0.1%−630,200−39.6%ReducedHolders
Q1 20241,590,380$8.08M<0.1%−164,600−9.4%ReducedHolders
Q4 20231,754,980$10.5M<0.1%+1,553,135+769.5%AddedHolders
Q3 2023201,845$1.43M<0.1%+201,845NewHolders
Q4 20220$00.0%−565,380−100.0%Sold outHolders
Q3 2022565,380$7.12M<0.1%+438,900+347.0%AddedHolders
Q2 2022126,480$1.34M<0.1%−125,000−49.7%ReducedHolders
Q1 2022251,480$4.09M<0.1%+251,480NewHolders
Q4 20210$00.0%−408,180−100.0%Sold outHolders
Q3 2021408,180$5.87M<0.1%−624,300−60.5%ReducedHolders
Q2 20211,032,480$16.3M<0.1%+965,010+1,430.3%AddedHolders
Q1 202167,470$686.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.